The Impact of Temporal Artery Biopsy at a UK Tertiary Plastic Surgery Unit
| Autor: | Javier Ibanez, Bryan J W Chew, Ankur Khajuria |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Retrospective review Unlikely diagnosis business.industry Significant difference lcsh:Surgery lcsh:RD1-811 030230 surgery Temporal artery biopsy medicine.disease Rheumatology 03 medical and health sciences Plastic surgery Giant cell arteritis 0302 clinical medicine Steroid therapy 030220 oncology & carcinogenesis Internal medicine medicine Surgery Original Article skin and connective tissue diseases business |
| Zdroj: | Plastic and Reconstructive Surgery Global Open Plastic and Reconstructive Surgery, Global Open, Vol 7, Iss 11, p e2541 (2019) |
| ISSN: | 2169-7574 |
| Popis: | Background:. Guidelines recommend temporal artery biopsy (TAB) for patients suspected of having giant cell arteritis (GCA). We evaluated the impact of TAB on the diagnosis and management of patients with suspected GCA at a tertiary plastic surgery unit. Methods:. A retrospective review of all TAB procedures performed at our centre over 7 years was performed. One hundred and one patients were included in the study. Patients were classified into 3 diagnostic groups: confirmed (positive TAB), presumed (negative TAB with high clinical suspicion) and unlikely (negative TAB with low clinical suspicion). The clinical presentation and management for each group were compared. Results:. The average American College of Rheumatology (ACR) score was 3.07. The number of patients with an ACR score of ≥3 before TAB was 72 (71.3%) and remained the same after TAB. The number of patients who remained on steroid therapy was lower in the group with an unlikely diagnosis of GCA compared to the group with a confirmed diagnosis (p0.05). Conclusions:. This study found a significant difference in steroid treatment between those with confirmed GCA and those where the diagnosis was unlikely showing that TAB may support decisions regarding steroid therapy. However, TAB was inappropriately requested for patients whose pre-TAB ACR score was ≥3 as this score is sufficient for the diagnosis of GCA. Therefore, the use of TAB should be limited to cases of diagnostic uncertainty. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|